004397AB1

Accuray Inc

Could not find a ticker for this position, may be a filing error

A maker of radiation therapy machines used to treat cancer. Its best-known products are the CyberKnife, a robotic system that aims high-dose radiation at tumors from many angles, and the TomoTherapy system, which delivers radiation in a spiral pattern. Founded in 1990, the company traces its roots to Stanford University, where the CyberKnife's inventor, John Adler, developed the idea of pairing a robotic arm with a linear accelerator to target tumors anywhere in the body.

CONVERTIBLEUnderlying: ARAYCUSIP: 004397AB1HealthcareUS1 derivative reporter

3.75% Senior Convertible Notes due 2016

Ownership Activity Financials Filings

Insiders

Ranked by how much each holding moved in the last 5 years

Insider

Mayer Steven FDirector · 6 transactions

1.55M—

Granted 1.30M · Bought 250.0K

Winter Suzanne CPresident and CEO · 21 transactions

1.20M+182.9%

as of Jun 2025

Granted 1.69M · Bought 12.0K · Sold 233.0K

Levine JoshuaCEO, Director · 4 transactions

1.09M-1.4%

as of Sep 2021

Granted 501.0K · Sold 31.5K

Whitters Joseph EDirector · 7 transactions

667.7K+112.5%

Granted 203.4K · Bought 150.0K

Chalke SandeepSVP, Chief Commercial Officer · 12 transactions

419.8K—

Granted 769.7K · Sold 67.6K

Hoge MichaelSenior VP Global Operations · 15 transactions

357.4K+115.8%

as of Dec 2024

Granted 501.3K · Sold 82.7K

Pervaiz AliSVP Chief Financial Officer · 21 transactions

352.9K—

Granted 436.4K · Sold 64.1K

Chew JesseChief Legal Officer · 14 transactions

326.8K+307.7%

as of Dec 2024

Granted 520.2K · Sold 74.8K

Hindman James M.Director · 4 transactions

294.8K+222.7%

Granted 203.4K

Le Grand Anne BryceDirector · 4 transactions

259.5K+363%

Granted 203.4K

Davila Elizabeth HDirector · 5 transactions

249.0K+19.5%

as of May 2023

Granted 90.2K

Huss Beverly ADirector · 9 transactions

244.0K+116.5%

Granted 203.4K

Spine PatrickSVP, Chief Admin Officer · 12 transactions

219.5K+77.7%

as of Dec 2023

Granted 291.1K · Sold 49.6K

Nishimura MikaDirector · 5 transactions

212.7K—

Granted 212.7K

Corradetti GInaVP, CAO and Controller · 2 transactions

196.1K—

as of Jan 2024

Granted 52.3K · Sold 14.1K

Pettingill RichardDirector · 3 transactions

180.4K+3%

as of Nov 2022

Granted 31.2K

Green Brandon WVP, Interim CFO · 4 transactions

174.5K—

as of Sep 2022

Granted 61.5K · Sold 19.1K

Palomba Franco NVP, Chief Accounting Officer · 1 transaction

173.5K—

as of Jun 2022

Granted 173.5K

Kill RobertDirector · 3 transactions

162.8K—

Granted 162.8K

Scott Byron CDirector · 12 transactions

162.7K+435.6%

Granted 212.9K · Bought 9.0K

Peralta LeonelSVP, Chief Operations Officer · 2 transactions

54.8K—

Granted 83.7K

Galbato ChanDirector · 1 transaction

50.0K—

Granted 50.0K

Murphy Michael JohnVP, Corporate Controller · 2 transactions

25.5K—

Granted 37.5K

La Neve Stephen R.CEO, Director · 1 transaction

20.0K—

Bought 20.0K

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Mayer Steven FDirector · 6 transactions	—	1.55M	1.30M	250.0K	—
Winter Suzanne CPresident and CEO · 21 transactions	+182.9%	1.20Mas of Jun 2025	1.69M	12.0K	233.0K
Levine JoshuaCEO, Director · 4 transactions	-1.4%	1.09Mas of Sep 2021	501.0K	—	31.5K
Whitters Joseph EDirector · 7 transactions	+112.5%	667.7K	203.4K	150.0K	—
Chalke SandeepSVP, Chief Commercial Officer · 12 transactions	—	419.8K	769.7K	—	67.6K
Hoge MichaelSenior VP Global Operations · 15 transactions	+115.8%	357.4Kas of Dec 2024	501.3K	—	82.7K
Pervaiz AliSVP Chief Financial Officer · 21 transactions	—	352.9K	436.4K	—	64.1K
Chew JesseChief Legal Officer · 14 transactions	+307.7%	326.8Kas of Dec 2024	520.2K	—	74.8K
Hindman James M.Director · 4 transactions	+222.7%	294.8K	203.4K	—	—
Le Grand Anne BryceDirector · 4 transactions	+363%	259.5K	203.4K	—	—
Davila Elizabeth HDirector · 5 transactions	+19.5%	249.0Kas of May 2023	90.2K	—	—
Huss Beverly ADirector · 9 transactions	+116.5%	244.0K	203.4K	—	—
Spine PatrickSVP, Chief Admin Officer · 12 transactions	+77.7%	219.5Kas of Dec 2023	291.1K	—	49.6K
Nishimura MikaDirector · 5 transactions	—	212.7K	212.7K	—	—
Corradetti GInaVP, CAO and Controller · 2 transactions	—	196.1Kas of Jan 2024	52.3K	—	14.1K
Pettingill RichardDirector · 3 transactions	+3%	180.4Kas of Nov 2022	31.2K	—	—
Green Brandon WVP, Interim CFO · 4 transactions	—	174.5Kas of Sep 2022	61.5K	—	19.1K
Palomba Franco NVP, Chief Accounting Officer · 1 transaction	—	173.5Kas of Jun 2022	173.5K	—	—
Kill RobertDirector · 3 transactions	—	162.8K	162.8K	—	—
Scott Byron CDirector · 12 transactions	+435.6%	162.7K	212.9K	9.0K	—
Peralta LeonelSVP, Chief Operations Officer · 2 transactions	—	54.8K	83.7K	—	—
Galbato ChanDirector · 1 transaction	—	50.0K	50.0K	—	—
Murphy Michael JohnVP, Corporate Controller · 2 transactions	—	25.5K	37.5K	—	—
La Neve Stephen R.CEO, Director · 1 transaction	—	20.0K	—	20.0K	—

Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.